Shopping Cart 0
Cart Subtotal
AED 0

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Les Laboratoires Servier SAS-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company's portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women's and male health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. It sells its products in Europe, North America, South America, Middle East, Africa and Asia. Servier headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Jul 17,2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics

Jul 16,2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France

Jun 19,2019: Servier breaks ground of Servier Paris-Saclay Research Institute

Jun 06,2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology

Jun 03,2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Les Laboratoires Servier SAS-Key Facts

Les Laboratoires Servier SAS-Key Employees

Les Laboratoires Servier SAS-Major Products and Services

Les Laboratoires Servier SAS-History

Les Laboratoires Servier SAS-Company Statement

Les Laboratoires Servier SAS-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Les Laboratoires Servier SAS-Business Description

Les Laboratoires Servier SAS-Corporate Strategy

Les Laboratoires Servier SAS-SWOT Analysis

SWOT Analysis-Overview

Les Laboratoires Servier SAS-Strengths

Les Laboratoires Servier SAS-Weaknesses

Les Laboratoires Servier SAS-Opportunities

Les Laboratoires Servier SAS-Threats

Les Laboratoires Servier SAS-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Les Laboratoires Servier SAS, Recent Deals Summary

Section 4-Company's Recent Developments

Jul 17, 2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics

Jul 16, 2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France

Jun 19, 2019: Servier breaks ground of Servier Paris-Saclay Research Institute

Jun 06, 2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology

Jun 03, 2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket

Apr 04, 2019: Servier joins access accelerated to fight against non-communicable diseases

Jan 31, 2019: Servier: 2017-2018 Financial Figures

Dec 04, 2018: Servier joins Embleema's blockchain health consortium to launch a pilot project for blockchain

Nov 05, 2018: Servier Launches InnoPreP Chromatography Service under its CDMO Business

Sep 19, 2018: Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Les Laboratoires Servier SAS, Key Facts

Les Laboratoires Servier SAS, Key Employees

Les Laboratoires Servier SAS, Major Products and Services

Les Laboratoires Servier SAS, History

Les Laboratoires Servier SAS, Subsidiaries

Les Laboratoires Servier SAS, Key Competitors

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Les Laboratoires Servier SAS, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Les Laboratoires Servier SAS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Sanofi

Pfizer Inc

NicOx SA

Laboratoires Thea SA

Laboratoires Pierre Fabre SA

Ipsen SA

Company Profile

Company Profile Title

Les Laboratoires Servier SAS-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company's portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women's and male health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. It sells its products in Europe, North America, South America, Middle East, Africa and Asia. Servier headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Jul 17,2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics

Jul 16,2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France

Jun 19,2019: Servier breaks ground of Servier Paris-Saclay Research Institute

Jun 06,2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology

Jun 03,2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Les Laboratoires Servier SAS-Key Facts

Les Laboratoires Servier SAS-Key Employees

Les Laboratoires Servier SAS-Major Products and Services

Les Laboratoires Servier SAS-History

Les Laboratoires Servier SAS-Company Statement

Les Laboratoires Servier SAS-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Les Laboratoires Servier SAS-Business Description

Les Laboratoires Servier SAS-Corporate Strategy

Les Laboratoires Servier SAS-SWOT Analysis

SWOT Analysis-Overview

Les Laboratoires Servier SAS-Strengths

Les Laboratoires Servier SAS-Weaknesses

Les Laboratoires Servier SAS-Opportunities

Les Laboratoires Servier SAS-Threats

Les Laboratoires Servier SAS-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Les Laboratoires Servier SAS, Recent Deals Summary

Section 4-Company's Recent Developments

Jul 17, 2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics

Jul 16, 2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France

Jun 19, 2019: Servier breaks ground of Servier Paris-Saclay Research Institute

Jun 06, 2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology

Jun 03, 2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket

Apr 04, 2019: Servier joins access accelerated to fight against non-communicable diseases

Jan 31, 2019: Servier: 2017-2018 Financial Figures

Dec 04, 2018: Servier joins Embleema's blockchain health consortium to launch a pilot project for blockchain

Nov 05, 2018: Servier Launches InnoPreP Chromatography Service under its CDMO Business

Sep 19, 2018: Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Les Laboratoires Servier SAS, Key Facts

Les Laboratoires Servier SAS, Key Employees

Les Laboratoires Servier SAS, Major Products and Services

Les Laboratoires Servier SAS, History

Les Laboratoires Servier SAS, Subsidiaries

Les Laboratoires Servier SAS, Key Competitors

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Les Laboratoires Servier SAS, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Les Laboratoires Servier SAS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Sanofi

Pfizer Inc

NicOx SA

Laboratoires Thea SA

Laboratoires Pierre Fabre SA

Ipsen SA